{"title":"Transition from schizotypal disorder to non-affective psychotic disorders including schizophrenia: A nationwide Swedish cohort study","authors":"S Lindström , J Nordgaard , J Berge","doi":"10.1016/j.psychres.2025.116470","DOIUrl":null,"url":null,"abstract":"<div><div>This study evaluated the transition rates from schizotypal disorder to non-affective psychosis and schizophrenia in particular aiming to identify clinical and demographic factors associated with these transitions. We conducted a nationwide cohort study using data from the Swedish Patient Register and the Cause of Death Register, including patients aged 18 and older diagnosed with schizotypal disorder (ICD-10 F21) between 2006 and 2017. Cox proportional hazards regression was employed to assess the associations between baseline characteristics and transitions to schizophrenia (ICD-10 F20) and other non-affective psychotic disorders (ICD-10 F20-F29, excluding F21), with follow-up extending up to 12 years. Of the 667 patients included, 12.0 % transitioned to schizophrenia, and 22.5 % to other non-affective psychotic disorders. The estimated 10-year cumulative risks of transition were 24.6 % for schizophrenia and 43.5 % for non-affective psychotic disorders. Older age and diagnosis allocated during the study's early observation years were associated with a reduced risk of transition to schizophrenia, while pre-existing depression and anxiety disorders had protective effects. In contrast, substance use disorders other than alcohol were associated with an increased risk of transitioning to non-affective psychotic disorders. These findings highlight that a significant portion of individuals with schizotypal disorder progress to more severe psychotic disorders, underlining the need for careful monitoring, especially in those with comorbid substance use.</div></div>","PeriodicalId":20819,"journal":{"name":"Psychiatry Research","volume":"348 ","pages":"Article 116470"},"PeriodicalIF":4.2000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165178125001180","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
This study evaluated the transition rates from schizotypal disorder to non-affective psychosis and schizophrenia in particular aiming to identify clinical and demographic factors associated with these transitions. We conducted a nationwide cohort study using data from the Swedish Patient Register and the Cause of Death Register, including patients aged 18 and older diagnosed with schizotypal disorder (ICD-10 F21) between 2006 and 2017. Cox proportional hazards regression was employed to assess the associations between baseline characteristics and transitions to schizophrenia (ICD-10 F20) and other non-affective psychotic disorders (ICD-10 F20-F29, excluding F21), with follow-up extending up to 12 years. Of the 667 patients included, 12.0 % transitioned to schizophrenia, and 22.5 % to other non-affective psychotic disorders. The estimated 10-year cumulative risks of transition were 24.6 % for schizophrenia and 43.5 % for non-affective psychotic disorders. Older age and diagnosis allocated during the study's early observation years were associated with a reduced risk of transition to schizophrenia, while pre-existing depression and anxiety disorders had protective effects. In contrast, substance use disorders other than alcohol were associated with an increased risk of transitioning to non-affective psychotic disorders. These findings highlight that a significant portion of individuals with schizotypal disorder progress to more severe psychotic disorders, underlining the need for careful monitoring, especially in those with comorbid substance use.
期刊介绍:
Psychiatry Research offers swift publication of comprehensive research reports and reviews within the field of psychiatry.
The scope of the journal encompasses:
Biochemical, physiological, neuroanatomic, genetic, neurocognitive, and psychosocial determinants of psychiatric disorders.
Diagnostic assessments of psychiatric disorders.
Evaluations that pursue hypotheses about the cause or causes of psychiatric diseases.
Evaluations of pharmacologic and non-pharmacologic psychiatric treatments.
Basic neuroscience studies related to animal or neurochemical models for psychiatric disorders.
Methodological advances, such as instrumentation, clinical scales, and assays directly applicable to psychiatric research.